Tahseen Malik, MD
Family Medicine · West Deptford, NJNPI 1447561121
Payments from drug & device makers
Across 125 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$219
- AstraZeneca$196
- Novo Nordisk$172
- Exact Sciences$123
- Johnson & Johnson$117
- Lilly USA, LLC$115
- plus $1K from 21 others
What the payments were for
- Food & beverage$1,991100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $219 |
| AstraZeneca | 13 | $196 |
| Novo Nordisk | 11 | $172 |
| Exact Sciences | 7 | $123 |
| Johnson & Johnson | 7 | $117 |
| Lilly USA, LLC | 7 | $115 |
| Pfizer | 6 | $105 |
| Abbott | 6 | $104 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $98 |
| GSK | 7 | $97 |
| Vanda Pharmaceuticals Inc. | 5 | $92 |
| Teva Pharmaceuticals USA, Inc. | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 5 | $80 |
| Astellas Pharma US Inc | 3 | $49 |
| Bayer | 3 | $48 |
| Amgen | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Novartis | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Ionis Pharmaceuticals, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
How this compares
$1,991 in reported general payments places this provider in the 75th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $379 |
| Atorvastatin Calcium | 45 | $379 |
| Quetiapine Fumarate | 20 | $338 |
| Lisinopril | 37 | $194 |
| Amlodipine Besylate | 31 | $184 |
| Hydrochlorothiazide | 21 | $171 |
| Fluticasone Propionate | 12 | $135 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 12 | $122 |
| Gabapentin | 12 | $103 |
| Omeprazole | 24 | $93 |
| Metoprolol Succinate | 11 | $67 |
| Ezetimibe | 13 | $46 |
| Amoxicillin | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other family medicine in West Deptford
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.